Cold Spring Harbor Laboratory Cancer Research Center

  • Mathews, Michael (PI)
  • Stillman, Bruce (PI)
  • Krainer, Adrian (PI)
  • Spector, David (PI)
  • Vakoc, Christopher (PI)
  • Lowe, Scott (PI)
  • Egeblad, Mikala (PI)
  • McCombie, William Richard (PI)
  • Herr, Winship (PI)
  • Roberts, Richard (PI)
  • Hannon, Gregory (PI)
  • Hannon, Gregory (PI)
  • Hannon, Gregory (PI)

Project Details


PROJECT SUMMARY - OVERALL The overall goal of this Program is to understand how basic cellular processes are altered and co-opted by cancer cells to promote tumor initiation and progression, and to apply this knowledge towards development of new therapeutic approaches. During the past 46 years, the strong underlying basic science foundation of the Program Project has allowed members to identify vulnerabilities in cancer and develop novel and highly specific therapeutic strategies. This Program continues to take a multi-pronged approach grounded in basic cancer research to identify and disrupt the molecular dependencies underlying cancer. Within this Program, there are five highly integrated Projects (Chromosome Inheritance; Regulation of Pre- mRNA Splicing in Tumorigenesis; Long Non-Coding RNAs and Cancer; Transcriptional Coactivators and Enhancers In Human Cancer; Tumor Suppressor and Tumor Maintenance Genes) and four innovative Cores that are using cutting edge technologies to study the molecular mechanisms of cancer biology. To achieve the Program's goals, these studies will exploit novel animal models of human cancers, pioneering functional genomics technologies, therapeutic antisense oligonucleotide strategies against otherwise undruggable targets, and cutting-edge methods in biochemistry, cell biology and molecular biology. The researchers will interrogate the basis of many of the most devastating types of tumors, including leukemias, breast, pancreatic, and highly aggressive liver cancers. All of this work is supported by four Cores that provide access to technologies, services, and expertise that all combine to enhance productivity and promote interactions. The interactive and collaborative nature of this Program guides each of these Projects beyond their singular potential. Research in all five Projects touches on overlapping themes and benefits from the expertise of the other Program members. Together, this Program is making significant progress towards its goal of identifying novel therapeutic targets that will substantially impact cancer treatment.
Effective start/end date12/31/891/31/22


  • National Cancer Institute


  • Genetics
  • Molecular Biology
  • Oncology
  • Radiology Nuclear Medicine and imaging
  • Cancer Research
  • Computer Science(all)
  • Cell Biology


Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.